KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitors.

PLoS One · 2012 · PMC3364990 · PMID 22675430

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

marginally significantp-value = 0.05actually significant

In the multivariate analysis, mucinous tumors were marginally significant (p-value = 0.05), with patients having mucinous tumors more frequently having PIK3CA mutations (OR 2.61; 95% CI 0.99–6.87).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.